Skip to main content
Figure 1 | Medical Gas Research

Figure 1

From: Extended normobaric hyperoxia therapy yields greater neuroprotection for focal transient ischemia-reperfusion in rats

Figure 1

Schematic representation of the protocol illustrates the timing of middle cerebral artery occlusion (MCAO) and reperfusion, normobaric hyperoxia therapy (NBO), 2,3,7-triphenyltetrazolium chloride (TTC) staining, NADPH oxidase expression, 8-hydroxy-deoxyguanosine (8-OHdG) immunohistochemistry, caspase-3 activity, terminal deoxynucleotidyl transferase-mediated uridine 5’-triphosphate-biotin nick end labeling (TUNEL) staining.

Back to article page